BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008;27:5124-5131. [PMID: 18758481 DOI: 10.1038/onc.2008.226] [Cited by in Crossref: 272] [Cited by in F6Publishing: 266] [Article Influence: 20.9] [Reference Citation Analysis]
Number Citing Articles
1 Vieceli Dalla Sega F, Fortini F, Aquila G, Campo G, Vaccarezza M, Rizzo P. Notch Signaling Regulates Immune Responses in Atherosclerosis. Front Immunol 2019;10:1130. [PMID: 31191522 DOI: 10.3389/fimmu.2019.01130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
2 Han J, Shen Q. Targeting γ-secretase in breast cancer. Breast Cancer (Dove Med Press). 2012;4:83-90. [PMID: 24367196 DOI: 10.2147/bctt.s26437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
3 Savonenko AV, Melnikova T, Hiatt A, Li T, Worley PF, Troncoso JC, Wong PC, Price DL. Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology 2012;37:261-77. [PMID: 21937983 DOI: 10.1038/npp.2011.211] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
4 Suh SS, Lee SG, Youn UJ, Han SJ, Kim IC, Kim S. Comprehensive Expression Profiling and Functional Network Analysis of Porphyra-334, One Mycosporine-Like Amino Acid (MAA), in Human Keratinocyte Exposed with UV-radiation. Mar Drugs 2017;15:E196. [PMID: 28672785 DOI: 10.3390/md15070196] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Stan SD, Singh SV, Whitcomb DC, Brand RE. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model. Nutr Cancer 2014;66:747-55. [PMID: 24195616 DOI: 10.1080/01635581.2013.795979] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
6 Xin Z, Wu X, Yu Z, Shang J, Xu B, Jiang S, Yang Y. Mechanisms explaining the efficacy of psoralidin in cancer and osteoporosis, a review. Pharmacological Research 2019;147:104334. [DOI: 10.1016/j.phrs.2019.104334] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
7 Wu J, Ji Z, Liu H, Liu Y, Han D, Shi C, Shi C, Wang C, Yang G, Chen X, Shen C, Li H, Bi Y, Zhang D, Zhao S. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway. Toxicol Lett 2013;220:61-9. [PMID: 23542114 DOI: 10.1016/j.toxlet.2013.03.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
8 Yang Y, Nakagawa H, Tetreault MP, Billig J, Victor N, Goyal A, Sepulveda AR, Katz JP. Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer. Cancer Res. 2011;71:6475-6484. [PMID: 21868761 DOI: 10.1158/0008-5472.CAN-11-1702] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
9 Moriwaki K, Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol 2010; 2(4): 151-161 [PMID: 21160988 DOI: 10.4254/wjh.v2.i4.151] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
10 Golde TE, Kukar TL. Medicine. Avoiding unintended toxicity. Science 2009;324:603-4. [PMID: 19407192 DOI: 10.1126/science.1174267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Marwarha G, Raza S, Hammer K, Ghribi O. 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer. Chem Phys Lipids 2017;207:108-26. [PMID: 28583434 DOI: 10.1016/j.chemphyslip.2017.05.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
12 Li H, Lan T, Xu L, Liu H, Wang J, Li J, Chen X, Huang J, Li X, Yuan K, Zeng Y, Wu H. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner. J Exp Clin Cancer Res 2020;39:128. [PMID: 32631394 DOI: 10.1186/s13046-020-01638-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 15.6] [Reference Citation Analysis]
14 Burns M, Armstrong SA, Gutierrez A. Pathobiology of Acute Lymphoblastic Leukemia. Hematology. Elsevier; 2018. pp. 1005-1019.e11. [DOI: 10.1016/b978-0-323-35762-3.00064-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D. A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer. 2012;48:997-1003. [PMID: 22445247 DOI: 10.1016/j.ejca.2012.02.056] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
16 Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J Cell Biochem. 2010;109:726-736. [PMID: 20052673 DOI: 10.1002/jcb.22451] [Cited by in Crossref: 13] [Cited by in F6Publishing: 93] [Article Influence: 1.2] [Reference Citation Analysis]
17 Yang Y, Tarapore RS, Jarmel MH, Tetreault MP, Katz JP. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle 2012;11:4033-9. [PMID: 22990386 DOI: 10.4161/cc.22265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kawaguchi Y, Kopetz S, Kwong L, Xiao L, Morris JS, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer. J Am Coll Surg 2021;233:272-284.e13. [PMID: 34111531 DOI: 10.1016/j.jamcollsurg.2021.05.027] [Reference Citation Analysis]
19 Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR. The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer. Medicines (Basel) 2018;5:E68. [PMID: 30004402 DOI: 10.3390/medicines5030068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Liu Z, Fan F, Wang A, Zheng S, Lu Y. Dll4-Notch signaling in regulation of tumor angiogenesis. J Cancer Res Clin Oncol 2014;140:525-36. [DOI: 10.1007/s00432-013-1534-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
21 Gammaitoni L, Leuci V, Mesiano G, Giraudo L, Todorovic M, Carnevale-Schianca F, Aglietta M, Sangiolo D. Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. Expert Opin Biol Ther 2014;14:1259-70. [PMID: 24835841 DOI: 10.1517/14712598.2014.918099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
22 Martin BM, Ivanova MH, Sarukhanov A, Kim A, Power P, Pugash D, Popescu O, Lachman RS, Krakow D, Patel MS. Prenatal and postnatal findings in serpentine fibula polycystic kidney syndrome and a review of the NOTCH2 spectrum disorders. Am J Med Genet 2014;164:2490-5. [DOI: 10.1002/ajmg.a.36656] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
23 Yao T, Lu R, Zhang Y, Zhang Y, Zhao C, Lin R, Lin Z. Cervical cancer stem cells. Cell Prolif 2015;48:611-25. [PMID: 26597379 DOI: 10.1111/cpr.12216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
24 Mittal S, Sharma A, Balaji SA, Gowda MC, Dighe RR, Kumar RV, Rangarajan A. Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers. Mol Cancer Ther 2014;13:3198-209. [PMID: 25253780 DOI: 10.1158/1535-7163.MCT-14-0280] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
25 D'Angelo RC, Ouzounova M, Davis A, Choi D, Tchuenkam SM, Kim G, Luther T, Quraishi AA, Senbabaoglu Y, Conley SJ, Clouthier SG, Hassan KA, Wicha MS, Korkaya H. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol Cancer Ther. 2015;14:779-787. [PMID: 25673823 DOI: 10.1158/1535-7163.mct-14-0228] [Cited by in Crossref: 73] [Cited by in F6Publishing: 44] [Article Influence: 12.2] [Reference Citation Analysis]
26 Guo L, Chen H, Li Y, Zhou Q, Sui Y. An aquaporin 3-notch1 axis in keratinocyte differentiation and inflammation. PLoS One 2013;8:e80179. [PMID: 24260356 DOI: 10.1371/journal.pone.0080179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
27 Gilbert CA, Daou MC, Moser RP, Ross AH. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 2010;70:6870-9. [PMID: 20736377 DOI: 10.1158/0008-5472.CAN-10-1378] [Cited by in Crossref: 82] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
28 Martin-Martin N, Sutherland JD, Carracedo A. PML: Not all about Tumor Suppression. Front Oncol 2013;3:200. [PMID: 23936764 DOI: 10.3389/fonc.2013.00200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
29 Patni AP, Harishankar MK, Joseph JP, Sreeshma B, Jayaraj R, Devi A. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications. Cell Oncol (Dordr) 2021;44:473-94. [PMID: 33704672 DOI: 10.1007/s13402-021-00591-3] [Reference Citation Analysis]
30 Deskin B, Yin Q, Zhuang Y, Saito S, Shan B, Lasky JA. Inhibition of HDAC6 Attenuates Tumor Growth of Non-Small Cell Lung Cancer. Transl Oncol 2020;13:135-45. [PMID: 31865176 DOI: 10.1016/j.tranon.2019.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
31 Liao B, Zhou H, Liang H, Li C. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma. Int J Oncol 2017;51:1449-59. [PMID: 29048612 DOI: 10.3892/ijo.2017.4126] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
32 Wuputra K, Ku CC, Wu DC, Lin YC, Saito S, Yokoyama KK. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells. J Exp Clin Cancer Res 2020;39:100. [PMID: 32493501 DOI: 10.1186/s13046-020-01584-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
33 Dandawate P, Padhye S, Ahmad A, Sarkar FH. Novel strategies targeting cancer stem cells through phytochemicals and their analogs. Drug Deliv Transl Res. 2013;3:165-182. [PMID: 24076568 DOI: 10.1007/s13346-012-0079-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
34 Tzeng TJ, Cao L, Fu Y, Zeng H, Cheng WH. Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin. PLoS One 2014;9:e101664. [PMID: 25010594 DOI: 10.1371/journal.pone.0101664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Steg AD, Katre AA, Goodman B, Han HD, Nick AM, Stone RL, Coleman RL, Alvarez RD, Lopez-Berestein G, Sood AK. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer. Clin Cancer Res. 2011;17:5674-5685. [PMID: 21753153 DOI: 10.1158/1078-0432.ccr-11-0432] [Cited by in Crossref: 83] [Cited by in F6Publishing: 52] [Article Influence: 8.3] [Reference Citation Analysis]
36 Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer. 2010;116:5676-5685. [PMID: 20737536 DOI: 10.1002/cncr.25551] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 8.1] [Reference Citation Analysis]
37 Yu H, Takeuchi H, Takeuchi M, Liu Q, Kantharia J, Haltiwanger RS, Li H. Structural analysis of Notch-regulating Rumi reveals basis for pathogenic mutations. Nat Chem Biol 2016;12:735-40. [PMID: 27428513 DOI: 10.1038/nchembio.2135] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
38 Cho ES, Kang HE, Kim NH, Yook JI. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT). Arch Pharm Res 2019;42:14-24. [PMID: 30649699 DOI: 10.1007/s12272-018-01108-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
39 Wang Y, Shen RW, Han B, Li Z, Xiong L, Zhang FY, Cong BB, Zhang B. Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats. World J Gastroenterol 2017; 23(13): 2330-2336 [PMID: 28428712 DOI: 10.3748/wjg.v23.i13.2330] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
40 Ring A, Zenz T. Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy. Haematologica 2020;105:1180-2. [PMID: 32358080 DOI: 10.3324/haematol.2020.246504] [Reference Citation Analysis]
41 Hassan WA, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Lung Cancer 2014;86:304-10. [PMID: 25456735 DOI: 10.1016/j.lungcan.2014.10.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
42 Kamstrup MR, Biskup E, Gjerdrum LM, Ralfkiaer E, Niazi O, Gniadecki R. The importance of Notch signaling in peripheral T-cell lymphomas. Leuk Lymphoma 2014;55:639-44. [PMID: 23697875 DOI: 10.3109/10428194.2013.807510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
43 Olsauskas-Kuprys R, Zlobin A, Osipo C. Gamma secretase inhibitors of Notch signaling. Onco Targets Ther 2013;6:943-55. [PMID: 23901284 DOI: 10.2147/OTT.S33766] [Cited by in Crossref: 27] [Cited by in F6Publishing: 67] [Article Influence: 3.4] [Reference Citation Analysis]
44 Locatelli M, Curigliano G. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. Current Opinion in Oncology 2017;29:411-27. [DOI: 10.1097/cco.0000000000000406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
45 Strizzi L, Hardy KM, Seftor EA, Costa FF, Kirschmann DA, Seftor RE, Postovit LM, Hendrix MJ. Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res. 2009;69:7131-7134. [PMID: 19738053 DOI: 10.1158/0008-5472.can-09-1199] [Cited by in Crossref: 63] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
46 Golde TE, Petrucelli L, Lewis J. Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp Neurol 2010;223:252-66. [PMID: 19716367 DOI: 10.1016/j.expneurol.2009.07.035] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
47 Danza G, Di Serio C, Rosati F, Lonetto G, Sturli N, Kacer D, Pennella A, Ventimiglia G, Barucci R, Piscazzi A, Prudovsky I, Landriscina M, Marchionni N, Tarantini F. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells. Mol Cancer Res 2012;10:230-8. [PMID: 22172337 DOI: 10.1158/1541-7786.MCR-11-0296] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
48 Espinosa-Sánchez A, Suárez-Martínez E, Sánchez-Díaz L, Carnero A. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Front Oncol 2020;10:1533. [PMID: 32984007 DOI: 10.3389/fonc.2020.01533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Maqsood A, Khoury T, Kumar P, Papanicolau-Sengos A, Early AP. Neuroendocrine Carcinoma of the Breast With Endobronchial Metastases and Syndrome of Inappropriate Antidiuretic Hormone Secretion. Clin Breast Cancer 2017;17:e229-32. [PMID: 28420584 DOI: 10.1016/j.clbc.2017.03.009] [Reference Citation Analysis]
50 Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013;1836:304-320. [PMID: 24183943 DOI: 10.1016/j.bbcan.2013.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
51 Windsor R, Strauss S, Seddon B, Whelan J. Experimental therapies in Ewing's sarcoma. Expert Opinion on Investigational Drugs 2009;18:143-59. [DOI: 10.1517/13543780802715784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
52 Restivo G, Nguyen BC, Dziunycz P, Ristorcelli E, Ryan RJ, Özuysal ÖY, Di Piazza M, Radtke F, Dixon MJ, Hofbauer GF, Lefort K, Dotto GP. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J 2011;30:4571-85. [PMID: 21909072 DOI: 10.1038/emboj.2011.325] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
53 Hassan KA. Small cell lung cancer heterogeneity: elevated a Notch above the Rest! J Thorac Dis 2018;10:554-6. [PMID: 29607110 DOI: 10.21037/jtd.2018.01.104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Tsiftsoglou AS, Bonovolias ID, Tsiftsoglou SA. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy. Pharmacology & Therapeutics 2009;122:264-80. [DOI: 10.1016/j.pharmthera.2009.03.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
55 Lombardo Y, Filipović A, Molyneux G, Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yagüe E, Michel L, Coombes RC. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. Proc Natl Acad Sci U S A 2012;109:16558-63. [PMID: 23012411 DOI: 10.1073/pnas.1206268109] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
56 Kawai T, Yasuchika K, Ishii T, Katayama H, Yoshitoshi EY, Ogiso S, Minami T, Miyauchi Y, Kojima H, Yamaoka R, Kita S, Yasuda K, Sasaki N, Fukumitsu K, Hatano E, Uemoto S. Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1. Cancer Med 2017;6:2531-40. [PMID: 28965351 DOI: 10.1002/cam4.1211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
57 Christopoulos PF, Gjølberg TT, Krüger S, Haraldsen G, Andersen JT, Sundlisæter E. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Front Immunol 2021;12:668207. [PMID: 33912195 DOI: 10.3389/fimmu.2021.668207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Broxterman HJ, Gotink KJ, Verheul HM. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat. 2009;12:114-126. [PMID: 19648052 DOI: 10.1016/j.drup.2009.07.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 129] [Article Influence: 11.7] [Reference Citation Analysis]
59 Kim Y, Joo KM, Jin J, Nam DH. Cancer stem cells and their mechanism of chemo-radiation resistance. Int J Stem Cells 2009;2:109-14. [PMID: 24855529 DOI: 10.15283/ijsc.2009.2.2.109] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
60 Qureshi MZ, Attar R, Romero MA, Sabitaliyevich UY, Nurmurzayevich SB, Ozturk O, Wakim LH, Lin X, Ozbey U, Yelekenova AB, Farooqi AA. Regulation of signaling pathways by β-elemene in cancer progression and metastasis. J Cell Biochem 2019;120:12091-100. [PMID: 30912190 DOI: 10.1002/jcb.28624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
61 Wang Z, Fukushima H, Gao D, Inuzuka H, Wan L, Lau AW, Liu P, Wei W. The two faces of FBW7 in cancer drug resistance. Bioessays 2011;33:851-9. [PMID: 22006825 DOI: 10.1002/bies.201100101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
62 Davis JB, Calvert V, Roberts S, Bracero S, Petricoin E, Couch R. Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway. Heliyon 2018;4:e00617. [PMID: 29872754 DOI: 10.1016/j.heliyon.2018.e00617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Rizzo P, Osipo C, Pannuti A, Golde T, Osborne B, Miele L. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. Adv Enzyme Regul 2009;49:134-41. [PMID: 19344631 DOI: 10.1016/j.advenzreg.2009.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
64 Mysliwiec P, Boucher MJ. Targeting Notch signaling in pancreatic cancer patients--rationale for new therapy. Adv Med Sci 2009;54:136-42. [PMID: 19758972 DOI: 10.2478/v10039-009-0026-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
65 Meisel CT, Porcheri C, Mitsiadis TA. Cancer Stem Cells, Quo Vadis? Cells. 2020;9:1879. [PMID: 32796631 DOI: 10.3390/cells9081879] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
66 Piazzi G, Fini L, Selgrad M, Garcia M, Daoud Y, Wex T, Malfertheiner P, Gasbarrini A, Romano M, Meyer RL, Genta RM, Fox JG, Boland CR, Bazzoli F, Ricciardiello L. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget 2011;2:1291-301. [PMID: 22249198 DOI: 10.18632/oncotarget.414] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
67 Liu S, Mitra R, Zhao MM, Fan W, Eischen CM, Yin F, Zhao Z. The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development. Mol Cancer Ther 2016;15:2977-86. [PMID: 27784795 DOI: 10.1158/1535-7163.MCT-16-0320] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
68 Golde TE, Ran Y, Felsenstein KM. Shifting a complex debate on γ-secretase cleavage and Alzheimer's disease. EMBO J 2012;31:2237-9. [PMID: 22505028 DOI: 10.1038/emboj.2012.111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
69 Diver EJ, Foster R, Rueda BR, Growdon WB. The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer. Oncologist 2015;20:1058-68. [PMID: 26099744 DOI: 10.1634/theoncologist.2015-0149] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
70 Gao XM, Zhang R, Dong QZ, Qin LX. Properties and feasibility of using cancer stem cells in clinical cancer treatment. Cancer Biol Med 2016;13:489-95. [PMID: 28154781 DOI: 10.20892/j.issn.2095-3941.2016.0076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
71 Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells 2010;28:639-48. [PMID: 20135685 DOI: 10.1002/stem.318] [Cited by in Crossref: 225] [Cited by in F6Publishing: 210] [Article Influence: 20.5] [Reference Citation Analysis]
72 Kalén M, Heikura T, Karvinen H, Nitzsche A, Weber H, Esser N, Ylä-Herttuala S, Hellström M. Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion. PLoS One 2011;6:e18709. [PMID: 21533193 DOI: 10.1371/journal.pone.0018709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
73 Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol Cancer Ther. 2012;11:1999-2009. [PMID: 22752426 DOI: 10.1158/1535-7163.mct-12-0017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
74 Medoro A, Bartollino S, Mignogna D, Passarella D, Porcile C, Pagano A, Florio T, Nizzari M, Guerra G, Di Marco R, Intrieri M, Raimo G, Russo C. Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer. J Alzheimers Dis 2018;61:1-15. [PMID: 29103038 DOI: 10.3233/JAD-170628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
75 Foss EJ, Radulovic D, Stirewalt DL, Radich J, Sala-Torra O, Pogosova-Agadjanyan EL, Hengel SM, Loeb KR, Deeg HJ, Meshinchi S, Goodlett DR, Bedalov A. Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets. J Proteome Res 2012;11:5005-10. [PMID: 22900933 DOI: 10.1021/pr300567r] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
76 Park DM, Rich JN. Biology of glioma cancer stem cells. Mol Cells 2009;28:7-12. [PMID: 19655094 DOI: 10.1007/s10059-009-0111-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 7.6] [Reference Citation Analysis]
77 Diaz-Padilla I, Hirte H, Oza AM, Clarke BA, Cohen B, Reedjik M, Zhang T, Kamel-Reid S, Ivy SP, Hotte SJ. A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors. Invest New Drugs. 2013;31:1182-1191. [PMID: 23860641 DOI: 10.1007/s10637-013-0001-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
78 He B, Chen J, Liu L, Wang H, Wang S, Li P, Zhou J. Knockdown of Tcf3 enhances the wound healing effect of bone marrow mesenchymal stem cells in rats. Biosci Rep 2019;39:BSR20180369. [PMID: 31085716 DOI: 10.1042/BSR20180369] [Reference Citation Analysis]
79 Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem 2011;112:78-88. [PMID: 20658545 DOI: 10.1002/jcb.22770] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
80 Petkau K, Ferguson M, Guntermann S, Foley E. Constitutive Immune Activity Promotes Tumorigenesis in Drosophila Intestinal Progenitor Cells. Cell Reports 2017;20:1784-93. [DOI: 10.1016/j.celrep.2017.07.078] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
81 Groth C, Fortini ME. Therapeutic approaches to modulating Notch signaling: current challenges and future prospects. Semin Cell Dev Biol 2012;23:465-72. [PMID: 22309842 DOI: 10.1016/j.semcdb.2012.01.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
82 Ren C, Yao Y, Han R, Huang Q, Li H, Wang B, Li S, Li M, Mao Y, Mao X, Xie L, Zhou L, Hu J, Ji X, Jin K. Cerebral ischemia induces angiogenesis in the peri-infarct regions via Notch1 signaling activation. Experimental Neurology 2018;304:30-40. [DOI: 10.1016/j.expneurol.2018.02.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
83 Ravi D, Wiles AM, Bhavani S, Ruan J, Leder P, Bishop AJ. A network of conserved damage survival pathways revealed by a genomic RNAi screen. PLoS Genet 2009;5:e1000527. [PMID: 19543366 DOI: 10.1371/journal.pgen.1000527] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
84 Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Front Oncol 2018;8:91. [PMID: 29666782 DOI: 10.3389/fonc.2018.00091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
85 Golde TE, Koo EH, Felsenstein KM, Osborne BA, Miele L. γ-Secretase inhibitors and modulators. Biochim Biophys Acta 2013;1828:2898-907. [PMID: 23791707 DOI: 10.1016/j.bbamem.2013.06.005] [Cited by in Crossref: 170] [Cited by in F6Publishing: 162] [Article Influence: 21.3] [Reference Citation Analysis]
86 Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, Ethier SP, Yang ZQ. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 2009;28:4491-500. [PMID: 19784073 DOI: 10.1038/onc.2009.297] [Cited by in Crossref: 141] [Cited by in F6Publishing: 128] [Article Influence: 11.8] [Reference Citation Analysis]
87 Pupo M, Pisano A, Abonante S, Maggiolini M, Musti AM. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs). Int J Biochem Cell Biol. 2014;46:56-67. [PMID: 24275097 DOI: 10.1016/j.biocel.2013.11.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
88 Nguyen NP, Almeida FS, Chi A, Nguyen LM, Cohen D, Karlsson U, Vinh-Hung V. Molecular biology of breast cancer stem cells: potential clinical applications. Cancer Treat Rev. 2010;36:485-491. [PMID: 20231058 DOI: 10.1016/j.ctrv.2010.02.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
89 Fortini F, Vieceli Dalla Sega F, Caliceti C, Lambertini E, Pannuti A, Peiffer DS, Balla C, Rizzo P. Estrogen-mediated protection against coronary heart disease: The role of the Notch pathway. J Steroid Biochem Mol Biol 2019;189:87-100. [PMID: 30817989 DOI: 10.1016/j.jsbmb.2019.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
90 Ciurea ME, Georgescu AM, Purcaru SO, Artene SA, Emami GH, Boldeanu MV, Tache DE, Dricu A. Cancer stem cells: biological functions and therapeutically targeting. Int J Mol Sci 2014;15:8169-85. [PMID: 24821540 DOI: 10.3390/ijms15058169] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
91 Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, Accili D. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med. 2013;19:1054-1060. [PMID: 23832089 DOI: 10.1038/nm.3259] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 11.9] [Reference Citation Analysis]
92 Mahmoodi S, Nezafat N, Negahdaripour M, Ghasemi Y. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties. Curr Mol Med 2019;19:2-11. [PMID: 30714514 DOI: 10.2174/1566524019666190204114721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
93 Yang X, Zhang Y, Huang Y, Wang Y, Qi X, Su T, Lu L. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases. Phytomedicine 2020;68:153176. [PMID: 32045841 DOI: 10.1016/j.phymed.2020.153176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Rivera M, Sukhdeo K, Yu J. Ionizing radiation in glioblastoma initiating cells. Front Oncol 2013;3:74. [PMID: 23579692 DOI: 10.3389/fonc.2013.00074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
95 Stewart DJ. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol 2010;75:173-234. [PMID: 20047843 DOI: 10.1016/j.critrevonc.2009.11.006] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 11.5] [Reference Citation Analysis]
96 Yamashita AS, Geraldo MV, Fuziwara CS, Kulcsar MA, Friguglietti CU, da Costa RB, Baia GS, Kimura ET. Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation. Transl Oncol 2013;6:197-205. [PMID: 23544172 DOI: 10.1593/tlo.12442] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
97 Baharlou R, Tajik N, Behdani M, Shokrgozar MA, Tavana V, Kazemi-lomedasht F, Faraji F, Habibi-anbouhi M. An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization. Immunopharmacology and Immunotoxicology 2018;40:368-74. [DOI: 10.1080/08923973.2018.1505907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
98 Chen X, Xiao W, Chen W, Liu X, Wu M, Bo Q, Luo Y, Ye S, Cao Y, Liu Y. MicroRNA-26a and -26b inhibit lens fibrosis and cataract by negatively regulating Jagged-1/Notch signaling pathway. Cell Death Differ 2017;24:1431-42. [PMID: 28622289 DOI: 10.1038/cdd.2016.152] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
99 Porcheri C, Meisel CT, Mitsiadis T. Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E1520. [PMID: 30917608 DOI: 10.3390/ijms20061520] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
100 Brzozowa M, Mielańczyk L, Michalski M, Malinowski L, Kowalczyk-Ziomek G, Helewski K, Harabin-Słowińska M, Wojnicz R. Role of Notch signaling pathway in gastric cancer pathogenesis. Contemp Oncol (Pozn) 2013;17:1-5. [PMID: 23788953 DOI: 10.5114/wo.2013.33765] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
101 Taleb S, Abbaszadegan MR, Moghbeli M, Roudbari NH, Forghanifard MM. HES1 as an Independent Prognostic Marker in Esophageal Squamous Cell Carcinoma. J Gastrointest Canc 2014;45:466-71. [DOI: 10.1007/s12029-014-9648-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
102 Rizzo AE, Yu JS. Radiation therapy for glioma stem cells. Adv Exp Med Biol 2015;853:85-110. [PMID: 25895709 DOI: 10.1007/978-3-319-16537-0_6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
103 Clay MR, Varma S, West RB. MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions. Hum Pathol 2013;44:2837-44. [PMID: 24140425 DOI: 10.1016/j.humpath.2013.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
104 Pagliaro L, Sorrentino C, Roti G. Targeting Notch Trafficking and Processing in Cancers. Cells 2020;9:E2212. [PMID: 33003595 DOI: 10.3390/cells9102212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
105 Abolghasemi M, Tehrani SS, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, Jadidi-Niaragh F, Yousefi M, Kafil HS, Bastami M, Edalati M, Eyvazi S, Naghizadeh M, Targhazeh N, Yousefi B, Safa A, Majidinia M, Rameshknia V. MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. J Cell Physiol 2020;235:5008-29. [PMID: 31724738 DOI: 10.1002/jcp.29396] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
106 Tung JJ, Tattersall IW, Kitajewski J. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2012;2:a006601. [PMID: 22355796 DOI: 10.1101/cshperspect.a006601] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
107 Forloni M, Dogra SK, Dong Y, Conte D Jr, Ou J, Zhu LJ, Deng A, Mahalingam M, Green MR, Wajapeyee N. miR-146a promotes the initiation and progression of melanoma by activating Notch signaling. Elife 2014;3:e01460. [PMID: 24550252 DOI: 10.7554/eLife.01460] [Cited by in Crossref: 75] [Cited by in F6Publishing: 48] [Article Influence: 10.7] [Reference Citation Analysis]
108 Lionberger JM, Stirewalt DL. Gene expression changes in normal haematopoietic cells. Best Pract Res Clin Haematol 2009;22:249-69. [PMID: 19698932 DOI: 10.1016/j.beha.2009.05.005] [Reference Citation Analysis]
109 Nwabo Kamdje AH, Seke Etet PF, Vecchio L, Muller JM, Krampera M, Lukong KE. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. Cell Signal. 2014;26:2843-2856. [PMID: 25093804 DOI: 10.1016/j.cellsig.2014.07.034] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
110 Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res 2011;71:1115-25. [PMID: 21245095 DOI: 10.1158/0008-5472.CAN-10-0690] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
111 Tomita T. Secretase inhibitors and modulators for Alzheimer’s disease treatment. Expert Review of Neurotherapeutics 2014;9:661-79. [DOI: 10.1586/ern.09.24] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 14.0] [Reference Citation Analysis]
112 Fortini F, Vieceli Dalla Sega F, Caliceti C, Aquila G, Pannella M, Pannuti A, Miele L, Ferrari R, Rizzo P. Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis. J Biol Chem 2017;292:18178-91. [PMID: 28893903 DOI: 10.1074/jbc.M117.790121] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
113 Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011;30:770-782. [PMID: 21224848 DOI: 10.1038/emboj.2010.349] [Cited by in Crossref: 254] [Cited by in F6Publishing: 236] [Article Influence: 25.4] [Reference Citation Analysis]
114 Dias BG, Goodman JV, Ahluwalia R, Easton AE, Andero R, Ressler KJ. Amygdala-dependent fear memory consolidation via miR-34a and Notch signaling. Neuron 2014;83:906-18. [PMID: 25123309 DOI: 10.1016/j.neuron.2014.07.019] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 11.7] [Reference Citation Analysis]
115 Shukrun R, Pode Shakked N, Dekel B. Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example. Pediatr Nephrol 2014;29:815-23; quiz 821. [PMID: 23760992 DOI: 10.1007/s00467-013-2501-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
116 Gilbert CA, Ross AH. Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem. 2009;108:1031-1038. [PMID: 19760641 DOI: 10.1002/jcb.22350] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 11.7] [Reference Citation Analysis]
117 Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 2011;19:192-205. [PMID: 21295524 DOI: 10.1016/j.ccr.2010.12.022] [Cited by in Crossref: 383] [Cited by in F6Publishing: 341] [Article Influence: 38.3] [Reference Citation Analysis]
118 Hassan WA, Ito T. Identifying specific Notch1 target proteins in lung carcinoma cells. Histol Histopathol 2021;36:69-76. [PMID: 33094831 DOI: 10.14670/HH-18-271] [Reference Citation Analysis]
119 Zlobin A, Bloodworth JC, Baker AT, Osipo C. Notch Signaling Pathway in Carcinogenesis. In: Badve S, Kumar GL, editors. Predictive Biomarkers in Oncology. Cham: Springer International Publishing; 2019. pp. 223-30. [DOI: 10.1007/978-3-319-95228-4_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
120 Łaska G, Maciejewska-Turska M, Sieniawska E, Świątek Ł, Pasco DS, Balachandran P. Extracts from Pulsatilla patens target cancer-related signaling pathways in HeLa cells. Sci Rep 2021;11:10654. [PMID: 34017038 DOI: 10.1038/s41598-021-90136-3] [Reference Citation Analysis]
121 Feng J, Wang J, Liu Q, Li J, Zhang Q, Zhuang Z, Yao X, Liu C, Li Y, Cao L, Li C, Gong L, Li D, Zhang Y, Gao H. DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling. Front Oncol 2019;9:809. [PMID: 31508369 DOI: 10.3389/fonc.2019.00809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
122 Shan H, Li X, Xiao X, Dai Y, Huang J, Song J, Liu M, Yang L, Lei H, Tong Y, Zhou L, Xu H, Wu Y. USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. Signal Transduct Target Ther 2018;3:29. [PMID: 30370059 DOI: 10.1038/s41392-018-0028-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
123 Shi L, Yin W, Zhang Z, Shi G. Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1. FEBS Open Bio 2016;6:1211-9. [PMID: 28203521 DOI: 10.1002/2211-5463.12135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
124 Hwang WL, Yang MH. Numb is involved in the non-random segregation of subcellular vesicles in colorectal cancer stem cells. Cell Cycle 2016;15:2697-703. [PMID: 27580100 DOI: 10.1080/15384101.2016.1218101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
125 Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface 2016;13:20151106. [PMID: 27170649 DOI: 10.1098/rsif.2015.1106] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 20.5] [Reference Citation Analysis]
126 Reyna MA, Leiserson MDM, Raphael BJ. Hierarchical HotNet: identifying hierarchies of altered subnetworks. Bioinformatics 2018;34:i972-80. [PMID: 30423088 DOI: 10.1093/bioinformatics/bty613] [Cited by in Crossref: 55] [Cited by in F6Publishing: 32] [Article Influence: 27.5] [Reference Citation Analysis]
127 Pindiprolu SKSS, Krishnamurthy PT, Dev C, Chintamaneni PK. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Chem Phys Lipids 2021;235:105033. [PMID: 33385372 DOI: 10.1016/j.chemphyslip.2020.105033] [Reference Citation Analysis]
128 Bighetti-Trevisan RL, Sousa LO, Castilho RM, Almeida LO. Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics. Stem Cells Int 2019;2019:9618065. [PMID: 31781251 DOI: 10.1155/2019/9618065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
129 Mentrup T, Loock AC, Fluhrer R, Schröder B. Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets? Biochim Biophys Acta Mol Cell Res 2017;1864:2169-82. [PMID: 28624439 DOI: 10.1016/j.bbamcr.2017.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
130 Sethi N, Yan Y, Quek D, Schupbach T, Kang Y. Rabconnectin-3 is a functional regulator of mammalian Notch signaling. J Biol Chem 2010;285:34757-64. [PMID: 20810660 DOI: 10.1074/jbc.M110.158634] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
131 Yadav AK, Srikrishna S, Gupta SC. Cancer Drug Development Using Drosophila as an in vivo Tool: From Bedside to Bench and Back. Trends Pharmacol Sci 2016;37:789-806. [PMID: 27298020 DOI: 10.1016/j.tips.2016.05.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
132 Lun SW, Cheung ST, Lo KW. Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma. Chin J Cancer 2014;33:529-38. [PMID: 25223912 DOI: 10.5732/cjc.014.10081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 0.3] [Reference Citation Analysis]
133 So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. J Steroid Biochem Mol Biol 2015;148:111-21. [PMID: 25541438 DOI: 10.1016/j.jsbmb.2014.12.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
134 Thomford NE, Dzobo K, Chimusa E, Andrae-marobela K, Chirikure S, Wonkam A, Dandara C. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 2018;22:375-91. [DOI: 10.1089/omi.2018.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
135 Song SG, Yu HY, Ma YW, Zhang F, Xu XY. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358. Tumour Biol 2016;37:13705-19. [PMID: 27476167 DOI: 10.1007/s13277-016-5134-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
136 Yahyanejad S, King H, Iglesias VS, Granton PV, Barbeau LM, van Hoof SJ, Groot AJ, Habets R, Prickaerts J, Chalmers AJ, Eekers DB, Theys J, Short SC, Verhaegen F, Vooijs M. NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma. Oncotarget 2016;7:41251-64. [PMID: 27183910 DOI: 10.18632/oncotarget.9275] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
137 Groeneweg JW, DiGloria CM, Yuan J, Richardson WS, Growdon WB, Sathyanarayanan S, Foster R, Rueda BR. Inhibition of notch signaling in combination with Paclitaxel reduces platinum-resistant ovarian tumor growth. Front Oncol 2014;4:171. [PMID: 25072022 DOI: 10.3389/fonc.2014.00171] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
138 Man CH, Wei-Man Lun S, Wai-Ying Hui J, To KF, Choy KW, Wing-Hung Chan A, Chow C, Tin-Yun Chung G, Tsao SW, Tak-Chun Yip T, Busson P, Lo KW. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. J Pathol 2012;226:471-81. [PMID: 22009689 DOI: 10.1002/path.2997] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
139 Lambertini C, Pantano S, Dotto GP. Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal vs cancer-derived keratinocytes. PLoS One. 2010;5:e10369. [PMID: 20442780 DOI: 10.1371/journal.pone.0010369] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
140 Osborne BA. B-CLL kicks it up a Notch. Blood 2009;113:765-6. [DOI: 10.1182/blood-2008-10-182998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Lee J, Song L, Terracina G, Bara T, Josien H, Asberom T, Sasikumar TK, Burnett DA, Clader J, Parker EM, Zhang L. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes. Biochemistry 2011;50:4973-80. [PMID: 21528914 DOI: 10.1021/bi200026m] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
142 Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Lindén M, Sahlgren C. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol Ther 2011;19:1538-46. [PMID: 21629222 DOI: 10.1038/mt.2011.105] [Cited by in Crossref: 155] [Cited by in F6Publishing: 136] [Article Influence: 15.5] [Reference Citation Analysis]
143 Deng G, Ma L, Meng Q, Ju X, Jiang K, Jiang P, Yu Z. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology. J Cancer Res Clin Oncol 2016;142:531-47. [PMID: 25736982 DOI: 10.1007/s00432-015-1946-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
144 VanderWielen BD, Yuan Z, Friedmann DR, Kovall RA. Transcriptional repression in the Notch pathway: thermodynamic characterization of CSL-MINT (Msx2-interacting nuclear target protein) complexes. J Biol Chem 2011;286:14892-902. [PMID: 21372128 DOI: 10.1074/jbc.M110.181156] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
145 Kim TH, Lee DK, Cho SN, Orvis GD, Behringer RR, Lydon JP, Ku BJ, McCampbell AS, Broaddus RR, Jeong JW. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. Cancer Res 2013;73:5090-9. [PMID: 23811943 DOI: 10.1158/0008-5472.CAN-13-0241] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
146 Pueyo JI, Couso JP. Tarsal-less peptides control Notch signalling through the Shavenbaby transcription factor. Dev Biol 2011;355:183-93. [PMID: 21527259 DOI: 10.1016/j.ydbio.2011.03.033] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
147 Iqbal J, Chong PY, Tan PH. Breast cancer stem cells: an update. J Clin Pathol 2013;66:485-90. [PMID: 23322821 DOI: 10.1136/jclinpath-2012-201304] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
148 Wang Z, Li Y, Sarkar FH. Notch signaling proteins: legitimate targets for cancer therapy. Curr Protein Pept Sci 2010;11:398-408. [PMID: 20491628 DOI: 10.2174/138920310791824039] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
149 de Oliveira-Carlos V, Ganz J, Hans S, Kaslin J, Brand M. Notch receptor expression in neurogenic regions of the adult zebrafish brain. PLoS One 2013;8:e73384. [PMID: 24039926 DOI: 10.1371/journal.pone.0073384] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
150 Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 2010;292:141-8. [PMID: 20022691 DOI: 10.1016/j.canlet.2009.11.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
151 Carroll AR, Coleman RL, Sood AK. Therapeutic advances in women's cancers. Front Biosci (Schol Ed) 2011;3:82-97. [PMID: 21196359 DOI: 10.2741/s134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
152 Abbas OL, Özatik O, Terzi YK, Özatik FY, Nar R, Turna G. The Notch Signaling System Is Involved in the Regulation of Reparative Angiogenesis in the Zone of Stasis. J Burn Care Res 2017;38:e923-33. [PMID: 28319529 DOI: 10.1097/BCR.0000000000000522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Baisiwala S, Hall RR 3rd, Saathoff MR, M Shireman J, Park C, Budhiraja S, Goel C, Warnke L, Hardiman C, Wang JY, McCortney K, Horbinski CM, Ahmed AU. LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma. Cancers (Basel) 2020;12:E3505. [PMID: 33255632 DOI: 10.3390/cancers12123505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, Shen M, Zhang L, Tupitsyn N, Pantel K, King C, Sun J, Moriguchi J, Jun HT, Coxon A, Lee B, Kang Y. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell 2017;32:731-747.e6. [PMID: 29232552 DOI: 10.1016/j.ccell.2017.11.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 19.3] [Reference Citation Analysis]
155 Li M, Chen F, Clifton N, Sullivan DM, Dalton WS, Gabrilovich DI, Nefedova Y. Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect. Mol Cancer Ther. 2010;9:3200-3209. [PMID: 21159606 DOI: 10.1158/1535-7163.mct-10-0372] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
156 Teicher BA. Antiangiogenic agents and targets: A perspective. Biochemical Pharmacology 2011;81:6-12. [DOI: 10.1016/j.bcp.2010.09.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
157 Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L. Targeting Notch to target cancer stem cells. Clin Cancer Res 2010;16:3141-52. [PMID: 20530696 DOI: 10.1158/1078-0432.CCR-09-2823] [Cited by in Crossref: 318] [Cited by in F6Publishing: 179] [Article Influence: 28.9] [Reference Citation Analysis]
158 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 4.3] [Reference Citation Analysis]
159 Dees C, Zerr P, Tomcik M, Beyer C, Horn A, Akhmetshina A, Palumbo K, Reich N, Zwerina J, Sticherling M. Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum. 2011;63:1396-1404. [PMID: 21312186 DOI: 10.1002/art.30254] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
160 Zhu M, Hu X, Cao G, Xue R, Gong C. Functions and impact of tal-like genes in animals with regard to applied aspects. Appl Microbiol Biotechnol 2018;102:6841-5. [PMID: 29909570 DOI: 10.1007/s00253-018-9159-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Wang Z, Li Y, Ahmad A, Azmi AS, Banerjee S, Kong D, Sarkar FH. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta. 2010;1806:258-267. [PMID: 20600632 DOI: 10.1016/j.bbcan.2010.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 102] [Article Influence: 4.0] [Reference Citation Analysis]
162 Ho DM, Artavanis-tsakonas S. The Notch-Mediated Proliferation Circuitry. Essays on Developmental Biology, Part A. Elsevier; 2016. pp. 17-33. [DOI: 10.1016/bs.ctdb.2015.12.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
163 Li W, Zhou J, Chen Y, Zhang G, Jiang P, Hong L, Shen Y, Wang X, Gong X. Cigarette smoke enhances initiation and progression of lung cancer by mutating Notch1/2 and dysregulating downstream signaling molecules. Oncotarget 2017;8:115128-39. [PMID: 29383147 DOI: 10.18632/oncotarget.22924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
164 Sahebjam S, Bedard PL, Castonguay V, Chen Z, Reedijk M, Liu G, Cohen B, Zhang WJ, Clarke B, Zhang T, Kamel-Reid S, Chen H, Ivy SP, Razak AR, Oza AM, Chen EX, Hirte HW, McGarrity A, Wang L, Siu LL, Hotte SJ. A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503). Br J Cancer 2013;109:943-9. [PMID: 23868004 DOI: 10.1038/bjc.2013.380] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
165 Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy. Molecules 2021;26:972. [PMID: 33673088 DOI: 10.3390/molecules26040972] [Reference Citation Analysis]
166 Ding L, Yuan C, Wei F, Wang G, Zhang J, Bellail AC, Zhang Z, Olson JJ, Hao C. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest 2011;29:511-20. [PMID: 21877938 DOI: 10.3109/07357907.2011.605412] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
167 Richter S, Bedard PL, Chen EX, Clarke BA, Tran B, Hotte SJ, Stathis A, Hirte HW, Razak AR, Reedijk M, Chen Z, Cohen B, Zhang WJ, Wang L, Ivy SP, Moore MJ, Oza AM, Siu LL, McWhirter E. A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575). Invest New Drugs. 2014;32:243-249. [PMID: 23645447 DOI: 10.1007/s10637-013-9965-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
168 Clementz AG, Osipo C. Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I? Breast Cancer Res 2009;11:110. [PMID: 19849815 DOI: 10.1186/bcr2407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
169 Hill L, Browne G, Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132:745-754. [PMID: 22753312 DOI: 10.1002/ijc.27708] [Cited by in Crossref: 154] [Cited by in F6Publishing: 153] [Article Influence: 17.1] [Reference Citation Analysis]
170 Li F, Zhao C, Wang L. Molecular-targeted agents combination therapy for cancer: developments and potentials. Int J Cancer 2014;134:1257-69. [PMID: 23649791 DOI: 10.1002/ijc.28261] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 9.8] [Reference Citation Analysis]
171 Ren Z, Zhang C, Ma L, Zhang X, Shi S, Tang D, Xu J, Hu Y, Wang B, Zhang F, Zhang X, Zheng H. Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways. Int J Mol Med 2019;44:67-78. [PMID: 31115486 DOI: 10.3892/ijmm.2019.4186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
172 Santos L, León-Galván MF, Marino-Marmolejo EN, Barba de la Rosa AP, De León Rodríguez A, González-Amaro R, Guevara-González RG. Identification of differential expressed transcripts in cervical cancer of Mexican patients. Tumour Biol 2011;32:561-8. [PMID: 21225484 DOI: 10.1007/s13277-010-0151-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
173 Sharma A, Gadkari RA, Ramakanth SV, Padmanabhan K, Madhumathi DS, Devi L, Appaji L, Aster JC, Rangarajan A, Dighe RR. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors. Sci Rep 2015;5:11012. [PMID: 26046801 DOI: 10.1038/srep11012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
174 Rossini M, Martini F, Torreggiani E, Fortini F, Aquila G, Sega FVD, Patergnani S, Pinton P, Maniscalco P, Cavallesco G, Rizzo P, Tognon M. Metformin Induces Apoptosis and Inhibits Notch1 in Malignant Pleural Mesothelioma Cells. Front Cell Dev Biol 2020;8:534499. [PMID: 33537296 DOI: 10.3389/fcell.2020.534499] [Reference Citation Analysis]
175 Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J Pathol 2011;225:353-63. [PMID: 21984123 DOI: 10.1002/path.2966] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
176 Tenjin Y, Kudoh S, Kubota S, Yamada T, Matsuo A, Sato Y, Ichimura T, Kohrogi H, Sashida G, Sakagami T, Ito T. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Lab Invest 2019;99:1622-35. [DOI: 10.1038/s41374-019-0277-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
177 Sarkar FH, Li Y, Wang Z, Kong D. Cellular signaling perturbation by natural products. Cell Signal 2009;21:1541-7. [PMID: 19298854 DOI: 10.1016/j.cellsig.2009.03.009] [Cited by in Crossref: 153] [Cited by in F6Publishing: 135] [Article Influence: 12.8] [Reference Citation Analysis]
178 Yedvobnick B, Moberg K. Linking model systems to cancer therapeutics: the case of Mastermind. Dis Model Mech 2010;3:540-4. [PMID: 20663965 DOI: 10.1242/dmm.005520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Liu J, Yang L, Wang X, Wang S, Huang Z, Li C, Liu Y, Cheng Y, Liu C, Wang Z. Embryonic stem cell microenvironment enhances proliferation of human retinal pigment epithelium cells by activating the PI3K signaling pathway. Stem Cell Res Ther 2020;11:411. [PMID: 32967731 DOI: 10.1186/s13287-020-01923-0] [Reference Citation Analysis]
180 Huang J, Chen Y, Li J, Zhang K, Chen J, Chen D, Feng B, Song H, Feng J, Wang R, Chen L. Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1. Mol Ther Nucleic Acids 2016;5:e375. [PMID: 27727250 DOI: 10.1038/mtna.2016.82] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
181 Xuan S, Shin DH, Kim J. Angiopep-2-conjugated liposomes encapsulating γ-secretase inhibitor for targeting glioblastoma stem cells. Journal of Pharmaceutical Investigation 2014;44:473-83. [DOI: 10.1007/s40005-014-0151-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
182 Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biology of the Cell 2012;104:3-12. [DOI: 10.1111/boc.201100115] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 10.1] [Reference Citation Analysis]
183 Parray A, Siddique HR, Nanda S, Konety BR, Saleem M. Castration-resistant prostate cancer: potential targets and therapies. Biologics 2012;6:267-76. [PMID: 22956858 DOI: 10.2147/BTT.S23954] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
184 Hou Y, Feng S, Wang L, Zhao Z, Su J, Yin X, Zheng N, Zhou X, Xia J, Wang Z. Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells. Oncotarget 2017;8:62120-30. [PMID: 28977931 DOI: 10.18632/oncotarget.19097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
185 Ayaz F, Osborne BA. Non-canonical notch signaling in cancer and immunity. Front Oncol 2014;4:345. [PMID: 25538890 DOI: 10.3389/fonc.2014.00345] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 12.4] [Reference Citation Analysis]
186 Brzozowa-Zasada M, Piecuch A, Dittfeld A, Mielańczyk Ł, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J, Wojnicz R. Notch signalling pathway as an oncogenic factor involved in cancer development. Contemp Oncol (Pozn) 2016;20:267-72. [PMID: 27688721 DOI: 10.5114/wo.2016.61845] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
187 Kreft AF, Martone R, Porte A. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease. J Med Chem 2009;52:6169-88. [PMID: 19694467 DOI: 10.1021/jm900188z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
188 Wu J, Wiegand R, LoRusso P, Li J. Validation and implementation of a liquid chromatography/tandem mass spectrometry assay for quantitation of the total and unbound RO4929097, a γ-secretase inhibitor targeting Notch signaling, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:1537-43. [PMID: 21497565 DOI: 10.1016/j.jchromb.2011.03.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
189 Dey P, Rathod M, De A. Targeting stem cells in the realm of drug-resistant breast cancer. Breast Cancer (Dove Med Press) 2019;11:115-35. [PMID: 30881110 DOI: 10.2147/BCTT.S189224] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
190 Ljungman M. Targeting the DNA damage response in cancer. Chem Rev 2009;109:2929-50. [PMID: 19545147 DOI: 10.1021/cr900047g] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]
191 Liu Y, Li P, Fan L, Wu M. The nuclear transportation routes of membrane-bound transcription factors. Cell Commun Signal 2018;16:12. [PMID: 29615051 DOI: 10.1186/s12964-018-0224-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
192 Yu W, Zhao S, Wang Y, Zhao BN, Zhao W, Zhou X. Identification of cancer prognosis-associated functional modules using differential co-expression networks. Oncotarget 2017;8:112928-41. [PMID: 29348878 DOI: 10.18632/oncotarget.22878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
193 Takam Kamga P, Bazzoni R, Dal Collo G, Cassaro A, Tanasi I, Russignan A, Tecchio C, Krampera M. The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche. Front Cell Dev Biol 2020;8:599276. [PMID: 33490067 DOI: 10.3389/fcell.2020.599276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Moserle L, Ghisi M, Amadori A, Indraccolo S. Side population and cancer stem cells: Therapeutic implications. Cancer Letters 2010;288:1-9. [DOI: 10.1016/j.canlet.2009.05.020] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
195 Espinoza I, Miele L. Notch inhibitors for cancer treatment. Pharmacol Ther 2013;139:95-110. [PMID: 23458608 DOI: 10.1016/j.pharmthera.2013.02.003] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 22.3] [Reference Citation Analysis]
196 Xiao Y, Ye Y, Zou X, Jones S, Yearsley K, Shetuni B, Tellez J, Barsky SH. The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction. Oncogene. 2011;30:287-300. [PMID: 20838375 DOI: 10.1038/onc.2010.405] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
197 Rizzo P, Mele D, Caliceti C, Pannella M, Fortini C, Clementz AG, Morelli MB, Aquila G, Ameri P, Ferrari R. The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors. Front Oncol 2014;4:384. [PMID: 25629006 DOI: 10.3389/fonc.2014.00384] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
198 Mamaeva V, Niemi R, Beck M, Özliseli E, Desai D, Landor S, Gronroos T, Kronqvist P, Pettersen IK, McCormack E, Rosenholm JM, Linden M, Sahlgren C. Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors. Mol Ther 2016;24:926-36. [PMID: 26916284 DOI: 10.1038/mt.2016.42] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
199 Amin ARMR, Karpowicz PA, Carey TE, Arbiser J, Nahta R, Chen ZG, Dong JT, Kucuk O, Khan GN, Huang GS, Mi S, Lee HY, Reichrath J, Honoki K, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bhakta D, Halicka D, Niccolai E, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Bilsland A, Shin DM. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol 2015;35 Suppl:S55-77. [PMID: 25749195 DOI: 10.1016/j.semcancer.2015.02.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 9.3] [Reference Citation Analysis]
200 McCleary-Wheeler AL, McWilliams R, Fernandez-Zapico ME. Aberrant signaling pathways in pancreatic cancer: a two compartment view. Mol Carcinog 2012;51:25-39. [PMID: 22162229 DOI: 10.1002/mc.20827] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
201 Li Y, Burns JA, Cheney CA, Zhang N, Vitelli S, Wang F, Bett A, Chastain M, Audoly LP, Zhang ZQ. Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies. Biologics 2010;4:163-71. [PMID: 20631820 DOI: 10.2147/btt.s11021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
202 He H, Liu R, Xiong W, Pu D, Wang S, Li T. Lentiviral vector-mediated down-regulation of Notch1 in endometrial stem cells results in proliferation and migration in endometriosis. Mol Cell Endocrinol 2016;434:210-8. [PMID: 27389878 DOI: 10.1016/j.mce.2016.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
203 Rooney P, Connolly M, Gao W, McCormick J, Biniecka M, Sullivan O, Kirby B, Sweeney C, Molloy E, Markham T, Fearon U, Veale DJ. Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol 2014;23:113-8. [PMID: 24330353 DOI: 10.1111/exd.12306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
204 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 2020;5:228. [PMID: 33028808 DOI: 10.1038/s41392-020-00313-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
205 Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs. 2009;1:12-25. [PMID: 20046569 DOI: 10.4161/mabs.1.1.7347] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 9.7] [Reference Citation Analysis]
206 Ding Y, Shen Y. Notch increased vitronection adhesion protects myeloma cells from drug induced apoptosis. Biochemical and Biophysical Research Communications 2015;467:717-22. [DOI: 10.1016/j.bbrc.2015.10.076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
207 Sarkar FH, Li Y, Wang Z, Kong D. Novel targets for prostate cancer chemoprevention. Endocr Relat Cancer 2010;17:R195-212. [PMID: 20576802 DOI: 10.1677/ERC-10-0074] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
208 Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett. 2014;349:8-14. [PMID: 24732808 DOI: 10.1016/j.canlet.2014.04.003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 186] [Article Influence: 28.4] [Reference Citation Analysis]
209 Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells. Mol Cancer 2017;16:28. [PMID: 28148265 DOI: 10.1186/s12943-017-0595-x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 18.3] [Reference Citation Analysis]
210 Ito T, Kudoh S, Ichimura T, Fujino K, Hassan WAMA, Udaka N. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1. Human Cell 2017;30:1-10. [DOI: 10.1007/s13577-016-0149-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
211 Landor SK, Mutvei AP, Mamaeva V, Jin S, Busk M, Borra R, Grönroos TJ, Kronqvist P, Lendahl U, Sahlgren CM. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc Natl Acad Sci U S A 2011;108:18814-9. [PMID: 22065781 DOI: 10.1073/pnas.1104943108] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
212 He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells. 2009;27:1487-1495. [PMID: 19544456 DOI: 10.1002/stem.92] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
213 Yoon DS, Cha DS, Alfhili MA, Keiper BD, Lee MH. Subunits of the DNA polymerase alpha-primase complex promote Notch-mediated proliferation with discrete and shared functions in C. elegans germline. FEBS J 2018;285:2590-604. [PMID: 29775245 DOI: 10.1111/febs.14512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
214 Rosati E, Sabatini R, De Falco F, Del Papa B, Falzetti F, Di Ianni M, Cavalli L, Fettucciari K, Bartoli A, Screpanti I, Marconi P. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. Int J Cancer 2013;132:1940-53. [DOI: 10.1002/ijc.27863] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
215 Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, Gibbon DG, Patnaik A, Falchook GS, Dasari A, Shapiro GI, Boylan JF, Xu ZX, Wang K, Koehler A, Song J, Middleton SA, Deutsch J, Demario M, Kurzrock R, Wheler JJ. Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol. 2012;30:2348-2353. [PMID: 22529266 DOI: 10.1200/jco.2011.36.8282] [Cited by in Crossref: 163] [Cited by in F6Publishing: 108] [Article Influence: 18.1] [Reference Citation Analysis]
216 Chen C, Zimmermann M, Tinhofer I, Kaufmann AM, Albers AE. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Letters 2013;338:47-56. [DOI: 10.1016/j.canlet.2012.06.013] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
217 Yousif NG, Sadiq AM, Yousif MG, Al-Mudhafar RH, Al-Baghdadi JJ, Hadi N. Notch1 ligand signaling pathway activated in cervical cancer: poor prognosis with high-level JAG1/Notch1. Arch Gynecol Obstet 2015;292:899-904. [PMID: 25842263 DOI: 10.1007/s00404-015-3694-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
218 Ferrari-Toninelli G, Bonini SA, Uberti D, Buizza L, Bettinsoli P, Poliani PL, Facchetti F, Memo M. Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells. Neuro Oncol 2010;12:1231-43. [PMID: 20716592 DOI: 10.1093/neuonc/noq101] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
219 de Vera Mudry MC, Regenass-Lechner F, Ozmen L, Altmann B, Festag M, Singer T, Müller L, Jacobsen H, Flohr A. Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells. Int J Alzheimers Dis 2012;2012:289412. [PMID: 23316412 DOI: 10.1155/2012/289412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
220 Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, Artavanis-Tsakonas S, Brugge JS. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci U S A 2010;107:5012-7. [PMID: 20194747 DOI: 10.1073/pnas.1000896107] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 10.1] [Reference Citation Analysis]
221 Pullamsetti SS, Savai R, Seeger W, Goncharova EA. Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs. Am J Respir Crit Care Med 2017;195:425-37. [PMID: 27627135 DOI: 10.1164/rccm.201606-1226PP] [Cited by in Crossref: 78] [Cited by in F6Publishing: 58] [Article Influence: 19.5] [Reference Citation Analysis]
222 Hanna A, Shevde LA. Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment. Mol Cancer 2016;15:24. [PMID: 26988232 DOI: 10.1186/s12943-016-0509-3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 100] [Article Influence: 18.0] [Reference Citation Analysis]
223 Chen JQ, Russo J. ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta 2009;1796:162-75. [PMID: 19527773 DOI: 10.1016/j.bbcan.2009.06.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 73] [Article Influence: 2.3] [Reference Citation Analysis]
224 Ye X, Tai W, Bao X, Chen X, Zhang D. FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells. Naunyn Schmiedebergs Arch Pharmacol 2014;387:75-85. [PMID: 24071813 DOI: 10.1007/s00210-013-0918-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
225 Liu L, Chen X, Wang Y, Qu Z, Lu Q, Zhao J, Yan X, Zhang H, Zhou Y. Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Ther 2014;21:364-72. [DOI: 10.1038/cgt.2014.39] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
226 Conboy IM, Yousef H, Conboy MJ. Embryonic anti-aging niche. Aging (Albany NY) 2011;3:555-63. [PMID: 21666284 DOI: 10.18632/aging.100333] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
227 Groeneweg JW, Hall TR, Zhang L, Kim M, Byron VF, Tambouret R, Sathayanrayanan S, Foster R, Rueda BR, Growdon WB. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model. Gynecologic Oncology 2014;133:607-15. [DOI: 10.1016/j.ygyno.2014.03.560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
228 O’flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O’leary J, O’byrne K. The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy. Journal of Thoracic Oncology 2012;7:1880-90. [DOI: 10.1097/jto.0b013e31826bfbc6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 42] [Article Influence: 9.1] [Reference Citation Analysis]
229 Li Y, Kong D, Bao B, Ahmad A, Sarkar FH. Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. Nutrients 2011;3:877-96. [PMID: 22200028 DOI: 10.3390/nu3100877] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
230 Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med. 2009;11:e12. [PMID: 19351437 DOI: 10.1017/s1462399409001033] [Cited by in Crossref: 113] [Cited by in F6Publishing: 72] [Article Influence: 9.4] [Reference Citation Analysis]
231 Caliceti C, Aquila G, Pannella M, Morelli MB, Fortini C, Pinton P, Bonora M, Hrelia S, Pannuti A, Miele L, Rizzo P, Ferrari R. 17β-estradiol enhances signalling mediated by VEGF-A-delta-like ligand 4-notch1 axis in human endothelial cells. PLoS One 2013;8:e71440. [PMID: 23967210 DOI: 10.1371/journal.pone.0071440] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
232 Morrison BJ, Morris JC, Steel JC. Lung cancer-initiating cells: a novel target for cancer therapy. Target Oncol. 2013;8:159-172. [PMID: 23314952 DOI: 10.1007/s11523-012-0247-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
233 Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97-106. [PMID: 21151206 DOI: 10.1038/nrclinonc.2010.196] [Cited by in Crossref: 656] [Cited by in F6Publishing: 607] [Article Influence: 59.6] [Reference Citation Analysis]
234 Opačak-Bernardi T, Ryu JS, Raucher D. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. J Drug Target 2017;25:523-31. [PMID: 28140690 DOI: 10.1080/1061186X.2017.1289537] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
235 Nasrin A, Hassan M, Ye P. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells. Biochem Biophys Res Commun 2018;495:2118-24. [PMID: 29253571 DOI: 10.1016/j.bbrc.2017.12.082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
236 Foroni C, Broggini M, Generali D, Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012;38:689-97. [PMID: 22118888 DOI: 10.1016/j.ctrv.2011.11.001] [Cited by in Crossref: 174] [Cited by in F6Publishing: 157] [Article Influence: 17.4] [Reference Citation Analysis]
237 Li Y, Hibbs MA, Gard AL, Shylo NA, Yun K. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1. Stem Cells 2012;30:741-52. [PMID: 22232070 DOI: 10.1002/stem.1030] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
238 López-Nieva P, González-Sánchez L, Cobos-Fernández MÁ, Córdoba R, Santos J, Fernández-Piqueras J. More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment. Oncologist 2021;26:e298-305. [PMID: 33191568 DOI: 10.1002/onco.13595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
239 Wael H, Yoshida R, Kudoh S, Hasegawa K, Niimori-Kita K, Ito T. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. Lung Cancer 2014;85:131-40. [PMID: 24888228 DOI: 10.1016/j.lungcan.2014.05.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
240 Han J, Hendzel MJ, Allalunis-Turner J. Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res 2011;13:210. [PMID: 21672271 DOI: 10.1186/bcr2875] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
241 Nandy SB, Lakshmanaswamy R. Cancer Stem Cells and Metastasis. Approaches to Understanding Breast Cancer. Elsevier; 2017. pp. 137-76. [DOI: 10.1016/bs.pmbts.2017.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
242 Lecanda F. Tumor–stroma: role of the tumor microenvironment during bone metastasis: unveiling therapeutic targets. Drug Discovery Today: Disease Models 2011;8:87-93. [DOI: 10.1016/j.ddmod.2011.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
243 Zhang L, Qi F, Gaudino G, Strianese O, Yang H, Morris P, Pass HI, Nerurkar VR, Bocchetta M, Carbone M. Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes. Genes Cancer 2010;1:1008-20. [PMID: 21779427 DOI: 10.1177/1947601910395580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
244 Venkatesh V, Nataraj R, Thangaraj GS, Karthikeyan M, Gnanasekaran A, Kaginelli SB, Kuppanna G, Kallappa CG, Basalingappa KM. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig. 2018;5:5. [PMID: 29682512 DOI: 10.21037/sci.2018.02.02] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 36.0] [Reference Citation Analysis]
245 Ito T. Intratumoral heterogeneity of Notch1 expression in small cell lung cancer. J Thorac Dis 2018;10:1272-5. [PMID: 29707277 DOI: 10.21037/jtd.2018.03.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Schott AF, Landis MD, Dontu G, Griffith KA, Layman RM, Krop I, Paskett LA, Wong H, Dobrolecki LE, Lewis MT. Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res. 2013;19:1512-1524. [PMID: 23340294 DOI: 10.1158/1078-0432.ccr-11-3326] [Cited by in Crossref: 153] [Cited by in F6Publishing: 90] [Article Influence: 19.1] [Reference Citation Analysis]
247 Hess S. The emerging field of chemo- and pharmacoproteomics. Proteomics Clin Appl 2013;7:171-80. [PMID: 23184895 DOI: 10.1002/prca.201200091] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
248 Saad MI, Rose-John S, Jenkins BJ. ADAM17: An Emerging Therapeutic Target for Lung Cancer. Cancers (Basel) 2019;11:E1218. [PMID: 31438559 DOI: 10.3390/cancers11091218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
249 Schepmann D, Wünsch B. Frontiers in Medicinal Chemistry 2010: the highlights. ChemMedChem 2010;5:949-54. [PMID: 20461748 DOI: 10.1002/cmdc.201000193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
250 Bozorgi A, Khazaei M, Khazaei MR. New Findings on Breast Cancer Stem Cells: A Review. J Breast Cancer 2015;18:303-12. [PMID: 26770236 DOI: 10.4048/jbc.2015.18.4.303] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 12.0] [Reference Citation Analysis]
251 Tiyanont K, Wales TE, Aste-Amezaga M, Aster JC, Engen JR, Blacklow SC. Evidence for increased exposure of the Notch1 metalloprotease cleavage site upon conversion to an activated conformation. Structure 2011;19:546-54. [PMID: 21481777 DOI: 10.1016/j.str.2011.01.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
252 Griewank KG, Wiesner T, Murali R, Pischler C, Müller H, Koelsche C, Möller I, Franklin C, Cosgarea I, Sucker A, Schadendorf D, Schaller J, Horn S, Brenn T, Mentzel T. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles. Mod Pathol 2018;31:418-28. [PMID: 29099504 DOI: 10.1038/modpathol.2017.146] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
253 Aoki S, Mizuma M, Takahashi Y, Haji Y, Okada R, Abe T, Karasawa H, Tamai K, Okada T, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Katayose Y, Unno M. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties. BMC Cancer. 2016;16:854. [PMID: 27821106 DOI: 10.1186/s12885-016-2919-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
254 Huo L, Wei W, Wu S, Zhao X, Zhao C, Zhao H, Sun L. Effect of dihydroarteminin combined with siRNA targeting Notch1 on Notch1/c-Myc signaling in T-cell lymphoma cells. Exp Ther Med 2018;15:3059-65. [PMID: 29599840 DOI: 10.3892/etm.2018.5784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
255 Aquila G, Fortini C, Pannuti A, Delbue S, Pannella M, Morelli MB, Caliceti C, Castriota F, de Mattei M, Ongaro A, Pellati A, Ferrante P, Miele L, Tavazzi L, Ferrari R, Rizzo P, Cremonesi A. Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: a pilot study. J Transl Med 2017;15:98. [PMID: 28472949 DOI: 10.1186/s12967-017-1199-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
256 Choi S, Yu J, Park A, Dubon MJ, Do J, Kim Y, Nam D, Noh J, Park KS. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling. Sci Rep 2019;9:11724. [PMID: 31409851 DOI: 10.1038/s41598-019-48190-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
257 Afshar Y, Jeong JW, Roqueiro D, DeMayo F, Lydon J, Radtke F, Radnor R, Miele L, Fazleabas A. Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse. FASEB J 2012;26:282-94. [PMID: 21990372 DOI: 10.1096/fj.11-184663] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
258 Hassan WA, Yoshida R, Kudoh S, Motooka Y, Ito T. Evaluation of role of Notch3 signaling pathway in human lung cancer cells. J Cancer Res Clin Oncol 2016;142:981-93. [PMID: 26838758 DOI: 10.1007/s00432-016-2117-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
259 Hubmann R, Düchler M, Schnabl S, Hilgarth M, Demirtas D, Mitteregger D, Hölbl A, Vanura K, Le T, Look T, Schwarzmeier JD, Valent P, Jäger U, Shehata M. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells. Br J Haematol 2010;148:868-78. [PMID: 19995395 DOI: 10.1111/j.1365-2141.2009.08024.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
260 Brahmi M, Bally O, Eberst L, Cassier P. Ciblage thérapeutique de la voie Notch en oncologie. Bulletin du Cancer 2017;104:883-91. [DOI: 10.1016/j.bulcan.2017.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
261 Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D, Roberts J, Cai J, Berkofsky-Fessler W, Hilton H. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res. 2009;69:7672-7680. [PMID: 19773430 DOI: 10.1158/0008-5472.can-09-1843] [Cited by in Crossref: 142] [Cited by in F6Publishing: 78] [Article Influence: 11.8] [Reference Citation Analysis]
262 Chen YX, Weng ZH, Zhang SL. Notch3 regulates the activation of hepatic stellate cells. World J Gastroenterol 2012; 18(12): 1397-1403 [PMID: 22493555 DOI: 10.3748/wjg.v18.i12.1397] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
263 Velcicky J, Bodendorf U, Rigollier P, Epple R, Beisner DR, Guerini D, Smith P, Liu B, Feifel R, Wipfli P, Aichholz R, Couttet P, Dix I, Widmer T, Wen B, Brandl T. Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. J Med Chem 2018;61:865-80. [DOI: 10.1021/acs.jmedchem.7b01371] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
264 Hovinga KE, Shimizu F, Wang R, Panagiotakos G, Van Der Heijden M, Moayedpardazi H, Correia AS, Soulet D, Major T, Menon J. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells. 2010;28:1019-1029. [PMID: 20506127 DOI: 10.1002/stem.429] [Cited by in Crossref: 195] [Cited by in F6Publishing: 163] [Article Influence: 17.7] [Reference Citation Analysis]
265 Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745-751. [PMID: 20041844 DOI: 10.2174/138945010791170860] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 16.4] [Reference Citation Analysis]
266 Rodrigues K, Oliveira M, Maretti-mira A, Oliveira-neto M, Mattos M, Silva L, Soares D, Dolci E, Perico R, Pirmez C. Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis: Notch system, IL-17 and IL-18 in cutaneous leishmaniasis. British Journal of Dermatology 2011;164:1228-34. [DOI: 10.1111/j.1365-2133.2011.10240.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
267 Aljedai A, Buckle AM, Hiwarkar P, Syed F. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL. PLoS One 2015;10:e0123016. [PMID: 25849484 DOI: 10.1371/journal.pone.0123016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]